The aim of this study was to evaluate the diagnostic effectiveness of pro-gastrin-releasing peptide (ProGRP) and chromogranin A (CgA) in the diagnosis of neuroendocrine neoplasms of the lung (LNENs), (290 cases) and compared these results with controls (54 cases). Here, GRP is linked to lung neuroendocrine neoplasm.